Plain-English translation of NCT06219759 on ClinicalTrials.gov ↗ ·
Researchers want to understand how the connection between nerves and muscles changes in people with ALS, and why some people progress more slowly than others. The study uses nerve stimulation tests, muscle ultrasound, strength measurements, and blood tests to track these changes over time. By studying these processes, doctors hope to identify markers that predict how fast ALS will progress.
In ALS, the nerves that control muscles gradually die, but the body sometimes tries to repair or rewire these connections—a process called reinnervation. Some people seem to have better reinnervation than others, which may help slow their disease. This study aims to identify blood markers and patterns that show which patients have stronger reinnervation capacity, potentially opening new ways to predict and treat ALS progression.
You likely qualify if…
You likely don't qualify if…
If you have suspected ALS, you'll start with one baseline visit including nerve stimulation tests, muscle ultrasound, blood draws, and strength assessments. If you're diagnosed with ALS, you'll return for two more visits at 4 and 8 months to repeat these tests and track how things change. Healthy volunteers and those with other motor neuron diseases will complete the baseline visit only. Most visits involve non-invasive tests and blood samples.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Denmark